Syncope: Distinguishing the Vanilla Faint From a Sudden Cardiac
... Workup included history, physical, 12-lead ECG, holter monitoring, ...
... Workup included history, physical, 12-lead ECG, holter monitoring, ...
File
... by Prevost1899 Defibrillation was invented in and Batelli, two Italian physiologists. They discovered that electric shocks could convert .ventricular fibrillation to sinus rhythm in dogs The first case of a human life saved by .1947defibrillation was reported by Beck in ...
... by Prevost1899 Defibrillation was invented in and Batelli, two Italian physiologists. They discovered that electric shocks could convert .ventricular fibrillation to sinus rhythm in dogs The first case of a human life saved by .1947defibrillation was reported by Beck in ...
Magnetic Resonance and Computed Tomography Imaging of
... disarray, and RVOT enlargement. Functional abnormalities include regional contraction abnormalities, aneurysms, RV global dilation/dysfunction, and RV diastolic dysfunction. The sites of involvement of these abnormalities are observed in the “triangle of dysplasia,” which is constituted by the infer ...
... disarray, and RVOT enlargement. Functional abnormalities include regional contraction abnormalities, aneurysms, RV global dilation/dysfunction, and RV diastolic dysfunction. The sites of involvement of these abnormalities are observed in the “triangle of dysplasia,” which is constituted by the infer ...
Chapter 19 Lecture Outline
... obstruction of coronary circulation – Atheroma (blood clot or fatty deposit) often obstructs coronary arteries – Cardiac muscle downstream of the blockage dies – Heavy pressure or squeezing pain radiating into the left arm – Some painless heart attacks may disrupt electrical conduction pathways, lea ...
... obstruction of coronary circulation – Atheroma (blood clot or fatty deposit) often obstructs coronary arteries – Cardiac muscle downstream of the blockage dies – Heavy pressure or squeezing pain radiating into the left arm – Some painless heart attacks may disrupt electrical conduction pathways, lea ...
CHD - ASD
... valve when output of the right ventricle is greater than that of the left ventricle (such as occurs in large atrial septal defects, a ventricular septal defect with left to right shunting, or right ventricular failure) ...
... valve when output of the right ventricle is greater than that of the left ventricle (such as occurs in large atrial septal defects, a ventricular septal defect with left to right shunting, or right ventricular failure) ...
Beneficial Neurohormonal Profile of Spironolactone in
... N-proANF levels could be related to an improvement of left ventricular diastolic properties and/or filling pressures. Spironolactone may prevent myocardial fibrosis by blocking the aldosterone effects on collagen formation, as suggested by decreased levels of collagen markers such as the procollagen ...
... N-proANF levels could be related to an improvement of left ventricular diastolic properties and/or filling pressures. Spironolactone may prevent myocardial fibrosis by blocking the aldosterone effects on collagen formation, as suggested by decreased levels of collagen markers such as the procollagen ...
2015-06-20 BMB cardiac sarcoidosis, manuscript
... used for diagnosis and monitoring of cardiac sarcoidosis are presented in table 3 and an example of their use in a patient with biopsy proven sarcoidosis is shown in figure 6. The diagnostic algorithm used in our own institution is presented in figure 7. Comparison of PET with other imaging modaliti ...
... used for diagnosis and monitoring of cardiac sarcoidosis are presented in table 3 and an example of their use in a patient with biopsy proven sarcoidosis is shown in figure 6. The diagnostic algorithm used in our own institution is presented in figure 7. Comparison of PET with other imaging modaliti ...
oral ab agora - European Heart Journal
... Department of Cardiology and Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands; 2Interuniversity Cardiology Institute of the Netherlands (ICIN), Utrecht, the Netherlands; 3Department of Physics and Medical Technology, VU University Medical Center, the Ne ...
... Department of Cardiology and Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands; 2Interuniversity Cardiology Institute of the Netherlands (ICIN), Utrecht, the Netherlands; 3Department of Physics and Medical Technology, VU University Medical Center, the Ne ...
2. carditis
... of the relative cardiac dullness shifted, or muffled tone deafness I, II Tone emphasis on the pulmonary artery , systolic murmur of a functional nature, or relative deficiency of the mitral valve. Paraclinical: Laboratory: laboratory results provide little information ECG electrical axis deviation t ...
... of the relative cardiac dullness shifted, or muffled tone deafness I, II Tone emphasis on the pulmonary artery , systolic murmur of a functional nature, or relative deficiency of the mitral valve. Paraclinical: Laboratory: laboratory results provide little information ECG electrical axis deviation t ...
2007_02_15-DaSilva-Advanced_ECG
... – Related to ventricular depolarization • Mean QRS vector = general direction of ventricular depolarization • Usually pointed downward and slightly to left since the “vectors” representing depolarization of left ventricle are larger due to thicker wall and septum (septum usually depolarizes from lef ...
... – Related to ventricular depolarization • Mean QRS vector = general direction of ventricular depolarization • Usually pointed downward and slightly to left since the “vectors” representing depolarization of left ventricle are larger due to thicker wall and septum (septum usually depolarizes from lef ...
Editorial - Circulation
... Death in Heart Failure Trial concludes that ICDs were cost-effective in that trial’s study population (New York Heart Association Class II or III heart failure with left ventricular ejection fraction no greater than 35%) “as long as the benefits of ICD therapy observed in the Sudden Cardiac Death in ...
... Death in Heart Failure Trial concludes that ICDs were cost-effective in that trial’s study population (New York Heart Association Class II or III heart failure with left ventricular ejection fraction no greater than 35%) “as long as the benefits of ICD therapy observed in the Sudden Cardiac Death in ...
- St George`s, University of London
... haemodynamic impairment such as dizziness, syncope or sudden extreme fatigue. As such, recommendations for competitive sports participation largely depend on the ventricular rate during AF episodes during exercise. If heart rate during atrial fibrillation is acceptable at maximum physical performanc ...
... haemodynamic impairment such as dizziness, syncope or sudden extreme fatigue. As such, recommendations for competitive sports participation largely depend on the ventricular rate during AF episodes during exercise. If heart rate during atrial fibrillation is acceptable at maximum physical performanc ...
ACLS Rhythms for the ACLS Algorithms
... ■ Palpitations felt by patient at the paroxysmal onset; becomes anxious, uncomfortable ■ Exercise tolerance low with very high rates ■ Symptoms of unstable tachycardia may occur ...
... ■ Palpitations felt by patient at the paroxysmal onset; becomes anxious, uncomfortable ■ Exercise tolerance low with very high rates ■ Symptoms of unstable tachycardia may occur ...
PDF - Thieme Connect
... years; male 63 %) with atrial fibrillation were examined by cardiac 64-slice multidetector CT before PVI. Extra-cardiac findings were classified as “significant” if they were recommended to additional diagnostics or therapy, and otherwise as “non-significant”. Additionally, cardiac findings were doc ...
... years; male 63 %) with atrial fibrillation were examined by cardiac 64-slice multidetector CT before PVI. Extra-cardiac findings were classified as “significant” if they were recommended to additional diagnostics or therapy, and otherwise as “non-significant”. Additionally, cardiac findings were doc ...
living with heart failure
... *A heart defect present at birth (congenital heart disease) *Infection of the heart valves (endocarditis) and/or heart muscle itself (myocarditis) ...
... *A heart defect present at birth (congenital heart disease) *Infection of the heart valves (endocarditis) and/or heart muscle itself (myocarditis) ...
Pericardial Effusion After Pediatric Cardiac Surgeries: A Single
... 22, moderate in 17, and severe in nine patients. The effusion was circumferential in 45 of 48 (94%) at first presentation. Of the three loculated effusions, two were small and one was moderate in size. There was no significant difference between genders in occurrence of PE. The prevalence of pericar ...
... 22, moderate in 17, and severe in nine patients. The effusion was circumferential in 45 of 48 (94%) at first presentation. Of the three loculated effusions, two were small and one was moderate in size. There was no significant difference between genders in occurrence of PE. The prevalence of pericar ...
TREATMENT IN BRADYCARDIA
... Evidence C) – Children who have third or advanced second-degree AV heart block after cardiac surgery that is not expected to resolve or that persists seven days after surgery (Level of Evidence B) – Congenital third-degree AV block with a wide QRS escape rhythm, complex ventricular ectopy, or ventri ...
... Evidence C) – Children who have third or advanced second-degree AV heart block after cardiac surgery that is not expected to resolve or that persists seven days after surgery (Level of Evidence B) – Congenital third-degree AV block with a wide QRS escape rhythm, complex ventricular ectopy, or ventri ...
Increased Central Venous Pressure Is Associated With
... and mean CVP (5.9 ⫾ 4.3 mm Hg) were within the normal range. The distribution of CVP among the study population is shown in Figure 1. Mean eGFR was moderately impaired: 65 ⫾ 24 ml/min/1.73 m2. The distribution of different factors over tertiles of CVP is shown in Table 2. Most of the characteristics ...
... and mean CVP (5.9 ⫾ 4.3 mm Hg) were within the normal range. The distribution of CVP among the study population is shown in Figure 1. Mean eGFR was moderately impaired: 65 ⫾ 24 ml/min/1.73 m2. The distribution of different factors over tertiles of CVP is shown in Table 2. Most of the characteristics ...
Congestive Heart Failure
... • An implantable cardioverter defibrillator (ICD). Some people with heart failure have very rapid, irregular heartbeats. Without treatment, the problem can cause sudden cardiac arrest. Doctors implant ICDs to solve this problem. ICDs are similar to pacemakers. The device checks your heart rate and c ...
... • An implantable cardioverter defibrillator (ICD). Some people with heart failure have very rapid, irregular heartbeats. Without treatment, the problem can cause sudden cardiac arrest. Doctors implant ICDs to solve this problem. ICDs are similar to pacemakers. The device checks your heart rate and c ...
Early predictors of adverse left ventricular remodelling after
... neurohormones and patency of the IRA, initial MI size and LVH to normalise wall stress [1–3, 11–14]. The benefits of primary PCI over thrombolysis in improving survival have been described [4]. One could expect a low prevalence of remodelling processes following mechanical reperfusion. Our data show ...
... neurohormones and patency of the IRA, initial MI size and LVH to normalise wall stress [1–3, 11–14]. The benefits of primary PCI over thrombolysis in improving survival have been described [4]. One could expect a low prevalence of remodelling processes following mechanical reperfusion. Our data show ...
Differential diagnosis of broad complex tachycardia
... When during tachycardia, the QRS is more narrow than during sinus rhythm, VT should be diagnosed. other factors that play a role in the QRS width • scar tissue (after MI) • ventricular hypertrophy • muscular disarray (as in HCM). ...
... When during tachycardia, the QRS is more narrow than during sinus rhythm, VT should be diagnosed. other factors that play a role in the QRS width • scar tissue (after MI) • ventricular hypertrophy • muscular disarray (as in HCM). ...
Cardiovascular autonomic nervous system
... Cardiovascular ANS assessment in RA has been studied by several investigators, and there have been conflicting results because of the way in which controls were selected and the criteria used to determine ANS dysfunction. Tests measuring heart rate variation have been most commonly employed, and the ...
... Cardiovascular ANS assessment in RA has been studied by several investigators, and there have been conflicting results because of the way in which controls were selected and the criteria used to determine ANS dysfunction. Tests measuring heart rate variation have been most commonly employed, and the ...
Mechanisms of Stretch Feedback and Interactions with
... During tonic stretch, driver potential and frequency of the heartbeat increased as a function of force, but only in CGs with long baseline burst durations. Since, in reality, the feedback from the heartbeat’s contraction act as series of short repeated stretches, I examined the ability of the heartb ...
... During tonic stretch, driver potential and frequency of the heartbeat increased as a function of force, but only in CGs with long baseline burst durations. Since, in reality, the feedback from the heartbeat’s contraction act as series of short repeated stretches, I examined the ability of the heartb ...
Surgical and Transcatheter Mitral Valve Repair for Severe Chronic
... current surgical indications for treatment of MR, almost 50% are not offered this therapy for reasons such as prohibitively high surgical risk from comorbidities, frailty associated with advanced age, lack of clinician familiarity with current guidelines, or a combination of these factors.6,7 Such p ...
... current surgical indications for treatment of MR, almost 50% are not offered this therapy for reasons such as prohibitively high surgical risk from comorbidities, frailty associated with advanced age, lack of clinician familiarity with current guidelines, or a combination of these factors.6,7 Such p ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.